BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24692704)

  • 1. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
    Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
    Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of thioridazine stereoisomers on the drug accumulation of mouse lymphoma and human prostate cancer cell lines in vitro.
    Csonka Á; Spengler G; Martins A; Ocsovszki I; Christensen JB; Hendricks O; Kristiansen JE; Amaral L; Molnar J
    In Vivo; 2013; 27(6):815-20. PubMed ID: 24292587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted steroidal compounds containing amino and amido groups reverse multidrug resistance of mouse T-lymphoma and two human prostate cancer cell lines in vitro.
    Csonka Á; Hamdoun S; Spengler G; Martins A; Vincze I; Efferth T; Molnár J
    Anticancer Res; 2015 Apr; 35(4):2105-12. PubMed ID: 25862866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
    Tang SJ; Chen LK; Wang F; Zhang YK; Huang ZC; To KK; Wang XK; Talele TT; Chen ZS; Chen WQ; Fu LW
    Biochem Pharmacol; 2014 Sep; 91(2):144-56. PubMed ID: 25058526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
    Pajak B; Molnar J; Engi H; Orzechowski A
    In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioridazine induces apoptosis of multidrug-resistant mouse lymphoma cells transfected with the human ABCB1 and inhibits the expression of P-glycoprotein.
    Spengler G; Molnar J; Viveiros M; Amaral L
    Anticancer Res; 2011 Dec; 31(12):4201-5. PubMed ID: 22199281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
    Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
    Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
    Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
    Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity.
    Wesołowska O; Molnar J; Ocsovszki I; Michalak K
    In Vivo; 2009; 23(6):943-7. PubMed ID: 20023237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
    Schmidt M; Teitge M; Castillo ME; Brandt T; Dobner B; Langner A
    Arch Pharm (Weinheim); 2008 Oct; 341(10):624-38. PubMed ID: 18816589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
    Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
    Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
    Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
    Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein.
    Si M; Zhao J; Li X; Tian JG; Li YG; Li JM
    Chin Med J (Engl); 2013 Nov; 126(21):4116-23. PubMed ID: 24229684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents.
    Zou ZH; Lan XB; Qian H; Huang WL; Li YM
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of calculated molecular orbital energies of some phenothiazine compounds with MDR reversal properties.
    Hilgeroth A; Molnár A; Molnár J; Voigt B
    Eur J Med Chem; 2006 Apr; 41(4):548-51. PubMed ID: 16516350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gambogic acid as a non-competitive inhibitor of ATP-binding cassette transporter B1 reverses the multidrug resistance of human epithelial cancers by promoting ATP-binding cassette transporter B1 protein degradation.
    Wang X; Deng R; Lu Y; Xu Q; Yan M; Ye D; Chen W
    Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):25-33. PubMed ID: 22759348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoralen reverses docetaxel-induced multidrug resistance in A549/D16 human lung cancer cells lines.
    Hsieh MJ; Chen MK; Yu YY; Sheu GT; Chiou HL
    Phytomedicine; 2014 Jun; 21(7):970-7. PubMed ID: 24703328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of P-glycoprotein transport function by N-acylphenothiazines.
    Wesolowska O; Molnár J; Motohashi N; Michalak K
    Anticancer Res; 2002; 22(5):2863-7. PubMed ID: 12530010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines.
    Molnar J; Molnar A; Mucsi I; Pinter O; Nagy B; Varga A; Motohashi N
    In Vivo; 2003; 17(2):145-9. PubMed ID: 12792975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.